1. AB0400 Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life. (15th June 2017) Authors: Pomponio, G; Tontini, C; Angeletti, A; Olivari, D; Benfaremo, D; Manfredi, L; Danieli, MG; Fraticelli, P; Luchetti, MM; Moroncini, G; Gabrielli, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tocilizumab for severe COVID-19 pneumonia. (November 2020) Authors: Piano, Salvatore; Vettor, Roberto; Angeli, Paolo; Arcidiacono, G; Benfaremo, D; Bettini, S; Bonora, BM; Bucca, G; Cattelan, A; Cerruti, L; Dalbeni, A; Framba, V; Gabrielli, A; Gambino, CG; Ghirardini, F; Gnudi, U; Luchetti, MM; Mantovani, A; Mareso, S; Marini, M Journal: Lancet Issue: Volume 2:Number 11(2020) Page Start: e659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗